InvestorsHub Logo
Followers 16
Posts 980
Boards Moderated 0
Alias Born 03/23/2013

Re: IET post# 16784

Saturday, 11/15/2014 8:06:45 AM

Saturday, November 15, 2014 8:06:45 AM

Post# of 140474
I totally agree. This could really cut down on manufacturing costs and Ximedica is now well funded by SV lifesciences. I don't understand HCs concern about Paul LaViolette. If Surgibot succeeds he wins as board director, but if SPORT and Ximedica hit home run he wins even bigger. Two totally different technologies. Younger surgeons coming out of training are going to prefer the telepresence full emersion robotic technology over bed side 3D glasses contraptions. Also, simulation training will fully engineered into it with is a plus. It is much easier to teach a novice surgeon in training to do a lap chole with full emersion technology than bedside training. This is important when consider the fact that for the last 8 or so years residency programs limit work hours for all residents to only 80 hours a week. Not enough for general surgeon. Sadly many surgeons are coming out of training ill equipped. I read an article stating that up to 20% of fresh out of training surgical residents couldn't do a lap chole by themselves! Think big picture HC.